Diagnostic performance of Food and Drug Administration - cleared serologicassays for natural rubber latex-specific IgE antibody

Citation
Rg. Hamilton et al., Diagnostic performance of Food and Drug Administration - cleared serologicassays for natural rubber latex-specific IgE antibody, J ALLERG CL, 103(5), 1999, pp. 925-930
Citations number
27
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
ISSN journal
00916749 → ACNP
Volume
103
Issue
5
Year of publication
1999
Part
1
Pages
925 - 930
Database
ISI
SICI code
0091-6749(199905)103:5<925:DPOFAD>2.0.ZU;2-Q
Abstract
Background: In the absence of Food and Drug Administration-approved natural rubber latex skin testing reagents, latex-specific IgE antibody immunoassa ys are used in the diagnosis of latex allergy. Comparative diagnostic perfo rmance of these tests has not been definitively determined. Objective: We sought to study the predictive value of available Food and Dr ug Administration (510K)-cleared latex-specific IgE antibody immunoassays i n the diagnosis of latex allergy. Methods: Subjects (n = 312) were classified as having a positive (n = 117) or a negative (n = 195) latex allergy history (Hx) or having a positive (n = 131) or a negative (n = 181) puncture skin test (PST) response (Greer rea gent). The 14 subjects with a negative Hx and a positive PST response had n egative responses to glove provocation testing and thus were considered sen sitized but asymptomatic. Sera from 22 subjects were split to evaluate intr a-assay variation. All 334 coded sera were analyzed for latex-specific IgE antibodies in the Diagnostic Products Corporation microplate AlaSTAT, Hycor HY-TEC EIA System, and Pharmacia-UpJohn CAP System. Variance and diagnosti c performance parameters of each test were computed with 95% confidence int ervals in relation to the subjects' Hx and PST status. Results: Intra-assay concordance of split sera results was 96.0% for all 3 assays, with coefficients of variation of less than 25% and between-assay c oefficients of variation of less than 21%. The diagnostic performance of th e CAP and AlaSTAT assays were equivalent in comparison with PST results: se nsitivity, CAP 76.3% and ALASTAT 73.3% and specificity, CAP 96.7% and AlaST AT 97.2% (P = NS). The HY-TEC assay was more sensitive (91.6%) and less spe cific (73.3%) than the CAP and AlaSTAT assays (P < .001). From 9% to 25% of the sera were discordant, being positive in at least 1, but not all 3, ass ays. Conclusion: The CAP and AlaSTAT assays produce 24% and 27% of false-negativ e results, respectively, whereas the HY-TEC produces 27% of false-positive results when compared with the PST.